Are These GLP-1 Trial Results About to Send Eli Lilly’s Stock Soaring?
The pharmaceutical company had a clinical setback earlier this year, but that's now in the rearview mirror. Over the past five years, Eli Lilly (LLY…
The pharmaceutical company had a clinical setback earlier this year, but that's now in the rearview mirror. Over the past five years, Eli Lilly (LLY…